| Apixaban Viatris 5 mg, Filmtabletten - 56 | | 70071005 | | Viatris Pharma GmbH | | Apixaban Viatris 5 mg, Filmtabletten | | 16.12.2025 | | | | | 16.12.2025 | | Apixaban (B01AF02) | | | | WHO-DDD | | 15.12.2030 | | | | 56 | | 06.03. | | | | | | | | No | | | | | | | | | | | | k.A. | | | | FB | | | | 7680700710053 | | Synthetika | | | | |
| | Composition | | apixabanum 5 mg, lactosum, cellulosum microcristallinum, carmellosum natricum conexum, natrii laurilsulfas, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, E 171, triacetinum, E 172 (rubrum), pro compresso obducto corresp. natrium 0.86 mg, lactosum 104 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Apixabanum | 5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactosum | 104 mg | | | Lactose Monohydrate | | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Pro Compresso Obducto | | | | Triacetinum | | |
|
| | Source | | | |
|
|
